Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · see citing works

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · see citing works

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · see citing works

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · see citing works

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · see citing works

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · see citing works

Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · see citing works

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960 · see citing works

Role of Genes and Environments for Explaining Alzheimer Disease

Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798 · see citing works

Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757 · see citing works

The role of apolipoprotein E in Alzheimer's disease

Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478 · see citing works

An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”

Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455 · see citing works

Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type

Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,380 · see citing works

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

Rovelet‐Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin‐Njock, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,249 · see citing works

ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050 · see citing works

Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N., & Beyreuther, K. T. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04000.x · Cited by 1,043 · see citing works

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · see citing works

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977 · see citing works

A Familial Alzheimer's Disease Locus on Chromosome 1

Levy‐Lahad, E., Wijsman, E. M., Nemens, E. J., Anderson, L., Goddard, K. A. B., Weber, J. L., Bird, T. D., & Schellenberg, G. D. (1995) · Science · doi:10.1126/science.7638621 · Cited by 811 · see citing works

Alzheimer's disease

Katzman, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141506 · Cited by 801 · see citing works

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene

Hendriks, L., van Duijn, C. M., Cras, P. P., Cruts, M., Hul, W. V., van Harskamp, F., Warren, A., McInnis, M. G., Antonarakis, S. E., Martin, J., et al. (1992) · Nature Genetics · doi:10.1038/ng0692-218 · Cited by 735 · see citing works

Epilepsy and Cognitive Impairments in Alzheimer Disease

Palop, J. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.15 · Cited by 684 · see citing works

Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease

Rumble, B. A., Retallack, R. W., Hilbich, C., Simms, G., Multhaup, G., Martins, R. N., Hockey, A., Montgomery, P., Beyreuther, K. T., & Masters, C. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906013202203 · Cited by 652 · see citing works

N OTCH AND P RESENILIN : Regulated Intramembrane Proteolysis Links Development and Degeneration

Selkoe, D. J., & Kopan, R. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131334 · Cited by 630 · see citing works

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

Sperling, R., Salloway, S., Brooks, D. J., Tampieri, D., Barakos, J., Fox, N. C., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70015-7 · Cited by 512 · see citing works

Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis

Ryman, D. C., Acosta-Baena, N., Aisen, P. S., Bird, T., Danek, A., Fox, N. C., Goate, A., Frommelt, P., Ghetti, B., Langbaum, J. B. S., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000596 · Cited by 502 · see citing works

The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology

Lemere, C. A., Lopera, F., Kosik, K. S., Lendon, C. L., Ossa, J., Saido, T. C., Yamaguchi, H., Ruiz, A., Martinez, A., Madrigal, L., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1146 · Cited by 487 · see citing works

Amyloid β Protein Precursor Gene and Hereditary Cerebral Hemorrhage with Amyloidosis (Dutch)

Broeckhoven, C. V., Haan, J., Bakker, E., Hardy, J., Hul, W. V., Wehnert, A., der Vlis, M. V.-V., & Roos, R. A. C. (1990) · Science · doi:10.1126/science.1971458 · Cited by 471 · see citing works

The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome

Mann, D. M. A., & Esiri, M. M. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90019-1 · Cited by 471 · see citing works

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease

Cruchaga, C., Karch, C. M., Jin, S. C., Benitez, B. A., Cai, Y., Guerreiro, R., Harari, O., Norton, J., Budde, J., Bertelsen, S., et al. (2014) · Nature · doi:10.1038/nature12825 · Cited by 461 · see citing works

Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related.

Wong, C. W., Quaranta, V., & Glenner, G. G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8729 · Cited by 438 · see citing works

Molecular mapping of alzheimer‐type dementia in Down's syndrome

Prasher, V. P., Farrer, M. J., Kessling, A. M., Fisher, E. M. C., West, R. J., Barber, P. C., & Butler, A. C. (1998) · Annals of Neurology · doi:10.1002/ana.410430316 · Cited by 414 · see citing works

Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder

George‐Hyslop, P. S., Haines, J. L., Farrer, L. A., Polinsky, R. J., Broeckhoven, C. V., Goate, A., McLachlan, D. R. C., Orr, H. T., Bruni, A. C., Sorbi, S., et al. (1990) · Nature · doi:10.1038/347194a0 · Cited by 392 · see citing works

Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees

Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., Bi, W., Hoge, J. A., Cohen, A. D., Ikonomovic, M. D., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-07.2007 · Cited by 389 · see citing works

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) · New England Journal of Medicine · doi:10.1056/nejmx120056 · Cited by 382 · see citing works

Alzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments

Reiman, E. M., Langbaum, J. B. S., Fleisher, A., Caselli, R. J., Chen, K., Ayutyanont, N., Quiroz, Y. T., Kosik, K. S., Lopera, F. J., & Tariot, P. N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0059 · Cited by 340 · see citing works

Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport

Pigino, G. F., Morfini, G. A., Pelsman, A., Mattson, M. P., Brady, S. T., & Busciglio, J. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04499.2003 · Cited by 300 · see citing works

Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer’s disease

Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Aggarwal, N. T., Arnold, S. E., Cochran, E. J., Berry-Kravis, E., & Bienias, J. L. (2003) · Neurology · doi:10.1212/01.wnl.0000042478.08543.f7 · Cited by 282 · see citing works

Hippocampal sclerosis in advanced age: clinical and pathological features

Nelson, P. T., Schmitt, F. A., Lin, Y., Abner, E. L., Jicha, G. A., Patel, E., Thomason, P. C., Neltner, J. H., Smith, C. D., Santacruz, K. S., et al. (2011) · Brain · doi:10.1093/brain/awr053 · Cited by 279 · see citing works

The amyloid precursor protein: A biochemical enigma in brain development, function and disease

Nalivaeva, N. N., & Turner, A. J. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.05.010 · Cited by 271 · see citing works

Brain Differences in Infants at Differential Genetic Risk for Late-Onset Alzheimer Disease: A Cross-sectional Imaging Study

Dean, D. C., Jerskey, B. A., Chen, K., Protas, H., Thiyyagura, P., Roontiva, A., O'Muircheartaigh, J., Dirks, H., Waskiewicz, N., Lehman, K., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4544 · Cited by 263 · see citing works

Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers

Potter, R., Patterson, B. W., Elbert, D. L., Ovod, V., Kasten, T., Sigurdson, W., Mawuenyega, K., Blazey, T., Goate, A., Chott, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005615 · Cited by 236 · see citing works

Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis

Wilcock, D. M., & Griffin, W. S. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-84 · Cited by 230 · see citing works

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

Olichney, J. M., Hansen, L. A., Galasko, D., Saitoh, T., Hofstetter, C. R., Katzman, R., & Thal, L. J. (1996) · Neurology · doi:10.1212/wnl.47.1.190 · Cited by 216 · see citing works

Developing an international network for Alzheimer’s research: the Dominantly Inherited Alzheimer Network

Morris, J. C., Aisen, P. S. S., Bateman, R. J., Benzinger, T. L. S., Cairns, N. J., Fagan, A. M., Ghetti, B. F., Goate, A., Holtzman, D. M., Klunk, W. E., et al. (2012) · Clinical Investigation · doi:10.4155/cli.12.93 · Cited by 205 · see citing works

What the evolution of the amyloid protein precursor supergene family tells us about its function

Coulson, E. J., Paliga, K., Beyreuther, K. T., & Masters, C. L. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00125-4 · Cited by 203 · see citing works

Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes

Hébert, S. S., Serneels, L., Tolia, A., Craessaerts, K., Derks, C., Filippov, M. A., Müller, U., & Strooper, B. D. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400704 · Cited by 190 · see citing works

Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ₄₂₍₄₃₎

Mann, D. M. A., Iwatsubo, T., Cairns, N. J., Lantos, P. L., Nochlin, D., Sumi, S. M., Bird, T. D., Poorkaj, P., Hardy, J., Hutton, M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400205 · Cited by 184 · see citing works

High Striatal Amyloid β-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation Types

Villemagne, V. L., Ataka, S., Mizuno, T., Brooks, W. S., Wada, Y., Kondo, M., Jones, G. R., Watanabe, Y., Mulligan, R. S., Nakagawa, M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.285 · Cited by 171 · see citing works

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic <i>APP</i> mutation carriers

Schöll, M., Wall, A., Thordardottir, S., Ferreira, D., Bogdanovic, N., Långström, B., Almkvist, O., Graff, C., & Nordberg, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31825fdf18 · Cited by 169 · see citing works

TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype

Davidson, Y. S., Raby, S., Foulds, P. G., Robinson, A., Thompson, J. C., Sikkink, S. K., Yusuf, I. H., Amin, H., DuPlessis, D., Troakes, C., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0879-y · Cited by 155 · see citing works

Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ1–42 mutants of familial Alzheimer's disease at positions 21–23

Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T., & Shirasawa, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00430-8 · Cited by 144 · see citing works

Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial

Mills, S., Mallmann, J., Santacruz, A. M., Fuqua, A., Carril, M. M. G., Aisen, P. S., Althage, M. C., Belyew, S., Benzinger, T. L. S., Brooks, W. S., et al. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.017 · Cited by 139 · see citing works

Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease

Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 137 · see citing works

The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain

Gómez‐Isla, T., Growdon, W. B., McNamara, M. J., Nochlin, D., Bird, T. D., Arango, J. C., Lopera, F., Kosik, K. S., Lantos, P. L., Cairns, N. J., et al. (1999) · Brain · doi:10.1093/brain/122.9.1709 · Cited by 128 · see citing works

Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · see citing works

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons

Knopman, D. S., Jack, C. R., Wiste, H. J., Lundt, E. S., Weigand, S. D., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.006 · Cited by 124 · see citing works

Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease

Pera, M., Alcolea, D. A., Sánchez‐Valle, R., Guardia‐Laguarta, C., Colom‐Cadena, M., Badiola, N., Suárez‐Calvet, M., Lladó, A., Barrera-Ocampo, A. A., Falla, D. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1062-9 · Cited by 122 · see citing works

Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease

Shinohara, M., Fujioka, S., Murray, M. E., Wojtas, A., Baker, M., Rovelet-Lecrux, A., Rademakers, R., Das, P., Parisi, J. E., Graff-Radford, N. R., et al. (2014) · Brain · doi:10.1093/brain/awu046 · Cited by 115 · see citing works

Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease

Basun, H., Bogdanovic, N., Ingelsson, M., Almkvist, O., Näslund, J., Axelman, K., Bird, T. D., Nochlin, D., Schellenberg, G. D., Wahlund, L.-O., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.499 · Cited by 115 · see citing works

Differential effect of <i>APOE</i> genotype on amyloid load and glucose metabolism in AD dementia

Ossenkoppele, R., van der Flier, W. M., Zwan, M. D., Adriaanse, S. F., Boellaard, R., Windhorst, A. D., Barkhof, F., Lammertsma, A. A., Scheltens, P., & van Berckel, B. N. M. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0889 · Cited by 112 · see citing works

Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people

Bennett, D. A. (2005) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp.2004.054445 · Cited by 99 · see citing works

The effect of APOE genotype on clinical phenotype in Alzheimer disease

van der Flier, W. M., Schoonenboom, S. N. M., Pijnenburg, Y. A. L., Fox, N. C., & Scheltens, P. (2006) · Neurology · doi:10.1212/01.wnl.0000228222.17111.2a · Cited by 98 · see citing works

Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques

Kumar‐Singh, S. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00380.x · Cited by 94 · see citing works

Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease

Portelius, E., Andréasson, U., Ringman, J. M., Büerger, K., Daborg, J., Buchhave, P., Hansson, O., Harmsen, A., Gustavsson, M. K., Hanse, E., et al. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-2 · Cited by 94 · see citing works

Familial Alzheimer’s Disease Mutations Differentially Alter Amyloid β-Protein Oligomerization

Gessel, M. M., Bernstein, S. L., Kemper, M., Teplow, D. B., & Bowers, M. T. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300050d · Cited by 93 · see citing works

Endocytic disturbances distinguish among subtypes of alzheimer's disease and related disorders

Cataldo, A., Rebeck, G. W., Ghetti, B., Hulette, C., Lippa, C., Van Broeckhoven, C., Van Duijn, C., Cras, P., Bogdanovic, N., Bird, T., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1254 · Cited by 90 · see citing works

FAMILIAL ORGANIC PSYCHOSIS (ALZHEIMER'S TYPE)

Lowenberg, K. (1934) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1934.02250040061004 · Cited by 83 · see citing works

Clinical Predictors of Severe Cerebral Amyloid Angiopathy and Influence ofAPOEGenotype in Persons With Pathologically Verified Alzheimer Disease

Ringman, J. M., Sachs, M. C., Zhou, Y. F., Monsell, S. E., Saver, J. L., & Vinters, H. V. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.681 · Cited by 82 · see citing works

APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory

Kerchner, G., Berdnik, D., Shen, J., Bernstein, J. D., Fenesy, M. C., Deutsch, G., Wyss-Coray, T., & Rutt, B. (2014) · Neurology · doi:10.1212/wnl.0000000000000154 · Cited by 82 · see citing works

Alzheimer's disease and endocytic dysfunction: Clues from the Down syndrome-related proteins, DSCR1 and ITSN1

Keating, D. J., Chen, C., & Pritchard, M. A. (2006) · Ageing Research Reviews · doi:10.1016/j.arr.2005.11.001 · Cited by 71 · see citing works

Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients

Lehmann, M., Ghosh, P., Madison, C. A., Karydas, A., Coppola, G., O’Neil, J. P., Huang, Y., Miller, B. L., Jagust, W., & Rabinovici, G. D. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305858 · Cited by 60 · see citing works

Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease.

Miklossy, J., Taddei, K., Suvà, D., Verdile, G., Fonte, J., Fisher, C. M., Gnjec, A., Ghika, J., Suard, F., Mehta, P., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00192-6 · Cited by 60 · see citing works

Comparison of clinical characteristics between familial and non-familial early onset Alzheimer’s disease

Karve, S. J., Ringman, J. M., Lee, A. S., Juarez, K. O., & Mendez, M. F. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6481-y · Cited by 58 · see citing works

Plasma Signaling Proteins in Persons at Genetic Risk for Alzheimer Disease

Ringman, J. M., Elashoff, D. A., Geschwind, D. H., Welsh, B. T., Gylys, K. H., Lee, C., Cummings, J. L., & Cole, G. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.277 · Cited by 55 · see citing works

Insensitivity to Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs and γ-Secretase Inhibitors Is Common among Aggressive Presenilin-1 Mutations

Czirr, E., Leuchtenberger, S., Dorner‐Ciossek, C., Schneider, A., Jucker, M., Koo, E. H., Pietrzik, C. U., Baumann, K., & Weggen, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700618200 · Cited by 55 · see citing works

Down's syndrome and Alzheimer's disease: towards secondary prevention

Ness, S. L., Rafii, M. S., Aisen, P. S. S., Krams, M., Silverman, W. P., & Manji, H. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3822 · Cited by 50 · see citing works

Ectopic White Matter Neurons, a Developmental Abnormality That May Be Caused by thePSEN1S169L Mutation in a Case of Familial AD with Myoclonus and Seizures

Takao, M., Ghetti, B. F., Murrell, J. R., Unverzagt, F. W., Giaccone, G., Tagliavini, F., Bugiani, O., Piccardo, P., Hulette, C. M., Crain, B. J., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1137 · Cited by 50 · see citing works

SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease

Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu372 · Cited by 49 · see citing works

Association of plasma and cortical amyloid beta is modulated by APOE ε4 status

Swaminathan, S., Risacher, S. L., Yoder, K. K., West, J. D., Shen, L., Kim, S., Inlow, M. H., Foroud, T., Jagust, W., Koeppe, R. A., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.007 · Cited by 45 · see citing works

Genetic Influences on Atrophy Patterns in Familial Alzheimer's Disease: A Comparison of APP and PSEN1 Mutations

Scahill, R. I., Ridgway, G. R., Bartlett, J. W., Barnes, J., Ryan, N. S., Mead, S., Beck, J. A., Clarkson, M. J., Crutch, S. J., Schott, J. M., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121255 · Cited by 45 · see citing works

Mosaicism for Trisomy 21 in a Patient With Young-Onset Dementia

Ringman, J. M., Rao, P. N., Lu, P. H., & Cederbaum, S. D. (2008) · Archives of Neurology · doi:10.1001/archneur.65.3.412 · Cited by 43 · see citing works

Relationship between Severe Amyloid Angiopathy, Apolipoprotein E Genotype, and Vascular Lesions in Alzheimer's Disease

Olichney, J., Hansen, L. A., Lee, J. H., Hofstetter, C. R., Katzman, R., & Thal, L. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06360.x · Cited by 43 · see citing works

Autosomal‐dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production

Suárez‐Calvet, M., Belbin, O., Pera, M., Badiola, N., Magrané, J., Guardia‐Laguarta, C., Muñoz, L., Colom‐Cadena, M., Clarimón, J., & Lleó, A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12466 · Cited by 41 · see citing works

Early Onset Familial Alzheimer Disease With Spastic Paraparesis, Dysarthria, and Seizures and N135S Mutation in PSEN1

Rudzinski, L. A., Fletcher, R. M., Dickson, D. W., Crook, R., Hutton, M. L., Adamson, J. L., & Graff‐Radford, N. R. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181732399 · Cited by 41 · see citing works

What the Study of Persons At Risk for Familial Alzheimer's Disease Can Tell Us About the Earliest Stages of the Disorder: A Review

Ringman, J. M. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281878 · Cited by 37 · see citing works

Presenilin regulates capacitative calcium entry dependently and independently of γ-secretase activity

Akbari, Y., Hitt, B. D., Murphy, M. P., Dagher, N. N., Tseng, B. P., Green, K. N., Golde, T. E., & LaFerla, F. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.136 · Cited by 31 · see citing works

A novel mutation in the PSEN1 gene (L286P) associated with familial early‐onset dementia of Alzheimer type and lobar haematomas

Sánchez‐Valle, R., Lladó, A., Ezquerra, M., Rey, M. J., Rami, L., & Molinuevo, J. L. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01988.x · Cited by 28 · see citing works

New Genes and New Insights from Old Genes

Ringman, J. M., & Coppola, G. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000429179.21977.a1 · Cited by 26 · see citing works

Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.

Roher, A. E., Maarouf, C. L., Malek‐Ahmadi, M. H., Wilson, J., Kokjohn, T. A., Daugs, I. D., Whiteside, C. M., Kalback, W. M., Macias, M. M. P., Jacobson, S. A., et al. (2013) · Europe PMC (PubMed Central) · Cited by 17 · see citing works

Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer\'s Related Pathological Changes in Down Syndrome

Decourt, B. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.s7-002 · Cited by 12 · see citing works

The exception makes the rule

Ringman, J. M., Teplow, D. B., & Villemagne, V. L. (2012) · Neurology · doi:10.1212/wnl.0b013e31825fe11f · Cited by 6 · see citing works

Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?

Lewerenz, J., & Maher, P. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00469 · Cited by 721 · see citing works

Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options

Cummings, J. L., Tong, G., & Ballard, C. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180766 · Cited by 588 · see citing works

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease

Rodriguez-Vieitez, E., Saint-Aubert, L., Carter, S. F., Almkvist, O., Farid, K. A., Schöll, M., Chiotis, K., Thordardottir, S., Graff, C., Wall, A., et al. (2016) · Brain : a journal of neurology · doi:10.1093/brain/awv404 · Cited by 285 · see citing works

Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis

Dapas, M., Lin, F. T. J., Nadkarni, G. N., Sisk, R., Legro, R. S., Urbanek, M., Hayes, M. G., & Dunaif, A. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003132 · Cited by 297 · see citing works

The neuroimmune axis of Alzheimer’s disease

Jorfi, M., Maaser‐Hecker, A., & Tanzi, R. E. (2023) · Genome Medicine · doi:10.1186/s13073-023-01155-w · Cited by 299 · see citing works

Combination Drug Therapy for the Management of Alzheimer’s Disease

Kabir, M. T., Uddin, M. S., Mamun, A. A., Jeandet, P., Aleya, L., Mansouri, R. A., Ashraf, G. M., Mathew, B., Bin-Jumah, M. N., & Abdel-Daim, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093272 · Cited by 217 · see citing works

Therapeutic Applications of Rose Hips from Different Rosa Species

Mármol, I., Sánchez‐de‐Diego, C., Jiménez‐Moreno, N., Ancín‐Azpilicueta, C., & Rodriguez‐Yoldi, M. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061137 · Cited by 213 · see citing works

The genes associated with early-onset Alzheimer’s disease

Dai, M.-H., Zheng, H., Zeng, L.-D., & Zhang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.23738 · Cited by 171 · see citing works

Past, present and future role of retinal imaging in neurodegenerative disease

Kashani, A. H., Asanad, S., Chan, J. W., Singer, M., Zhang, J., Sharifi, M., Khansari, M. M., Abdolahi, F., Shi, Y., Biffi, A., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100938 · Cited by 164 · see citing works

Beyond the average patient: how neuroimaging models can address heterogeneity in dementia

Verdi, S., Marquand, A. F., Schott, J. M., & Cole, J. H. (2021) · Brain · doi:10.1093/brain/awab165 · Cited by 106 · see citing works

The Promise of Multi-Omics and Clinical Data Integration to Identify and Target Personalized Healthcare Approaches in Autism Spectrum Disorders

Higdon, R., Earl, R. K., Stanberry, L. I., Hudac, C. M., Montague, E., Stewart, E., Janko, I., Choiniere, J., Broomall, W., Kolker, N., et al. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0020 · Cited by 103 · see citing works

Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database

Ringman, J. M., Monsell, S., Ng, D. W., Zhou, Y., Nguyen, A., Coppola, G., Van Berlo, V., Mendez, M. F., Tung, S., Weintraub, S., et al. (2016) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1093/jnen/nlv028 · Cited by 99 · see citing works

Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer’s disease

Gamberger, D., Lavrač, N., Srivatsa, S., Tanzi, R., & Doraiswamy, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-06624-y · Cited by 92 · see citing works

Sleep, Cognition and Dementia

Porter, V. R., Buxton, W. G., & Avidan, A. Y. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0631-8 · Cited by 94 · see citing works

Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease

Haberman, R. P., Branch, A., & Gallagher, M. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0541-z · Cited by 94 · see citing works

Revealing Individual Neuroanatomical Heterogeneity in Alzheimer Disease Using Neuroanatomical Normative Modeling

Verdi, S., Kia, S. M., Yong, K. X. X., Tosun, D., Schott, J. M., Marquand, A. F., Cole, J. H., & Initiative, T. A. D. N. (2023) · Neurology · doi:10.1212/wnl.0000000000207298 · Cited by 83 · see citing works

A genetic association study of CSMD1 and CSMD2 with cognitive function

Athanasiu, L., Giddaluru, S., Fernandes, C. P. D., Christoforou, A., Reinvang, I., Lundervold, A. J., Nilsson, L., Kauppi, K., Adolfsson, R., Eriksson, E., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.11.026 · Cited by 68 · see citing works

Prospects for the application of mesenchymal stem cells in Alzheimer's disease treatment

Chakari-Khiavi, F., Dolati, S., Chakari-Khiavi, A., Abbaszadeh, H., Maleki, L. A., Pourlak, T., Mehdizadeh, A., & Yousefi, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116564 · Cited by 59 · see citing works

An update on the genetics of dementia with Lewy bodies

Vergouw, L. J. M., van Steenoven, I., van de Berg, W. D. J., Teunissen, C. E., Swieten, J. C. V., Bonifati, V., Lemstra, A. W., & de Jong, F. J. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.009 · Cited by 47 · see citing works

Molecular Genetics of Early- and Late-Onset Alzheimer’s Disease

Uddin, M. S., Hasana, S., Hossain, M. F., Islam, M. S., Behl, T., Perveen, A., Hafeez, A., & Ashraf, G. M. (2020) · Current Gene Therapy · doi:10.2174/1566523220666201123112822 · Cited by 53 · see citing works

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Almeida, Z. L., Vaz, D. C., & Brito, R. M. M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04543-4 · Cited by 45 · see citing works

Reverse GWAS: Using genetics to identify and model phenotypic subtypes

Dahl, A. W., Cai, N., Ko, A., Laakso, M., Pajukanta, P., Jonathan Flint, C., & Zaitlen, N. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008009 · Cited by 42 · see citing works

Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease

Liu, H., Kim, C., Haldiman, T., Sigurdson, C. J., Nyström, S., Nilsson, K. P. R., Cohen, M. L., Wısnıewskı, T., Hammarström, P., & Safar, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101267 · Cited by 38 · see citing works

The dense-core plaques of Alzheimer’s disease are granulomas

Lemke, G., & Huang, Y. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20212477 · Cited by 37 · see citing works

Currents of memory: recent progress, translational challenges, and ethical considerations in fornix deep brain stimulation trials for Alzheimer's disease

Viaña, J. N. M., Vickers, J. C., Cook, M. J., & Gilbert, F. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.001 · Cited by 33 · see citing works

Extracellular Amyloid Deposits in Alzheimer’s and Creutzfeldt–Jakob Disease: Similar Behavior of Different Proteins?

Jankovská, N., Olejár, T., & Matěj, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010007 · Cited by 33 · see citing works

New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics

Lutz, M. W., Crenshaw, D. G., Welsh-Bohmer, K. A., Burns, D. K., & Roses, A. D. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0643-8 · Cited by 32 · see citing works

Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease

Chen, H., Eteleeb, A. M., Wang, C., Fernández, M. V., Budde, J., Bergmann, K., Norton, J. B., Wang, F., Ebl, C., Morris, J. C., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01328-5 · Cited by 31 · see citing works

A mixed‐methods study of cultural beliefs about dementia and genetic testing among Mexicans and Mexican‐Americans at‐risk for autosomal dominant Alzheimer’s disease

Withers, M. H., Sayegh, P., Rodríguez‐Agudelo, Y., Ernstrom, K. B., Raman, R., Montoya, L., Reyes, A. Z., Mosieri, C. N., Matute, E., & Ringman, J. M. (2019) · Journal of Genetic Counseling · doi:10.1002/jgc4.1133 · Cited by 30 · see citing works

Autosomal dominantly inherited alzheimer disease: Analysis of genetic subgroups by machine learning

Castillo-Barnés, D., Su, L., Ramı́rez, J., Salas-Gonzalez, D., Martínez-Murcia, F. J., Illán, I. A., Segovia, F., Ortíz, A., Cruchaga, C., Farlow, M. R., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.01.001 · Cited by 28 · see citing works

Advances in Alzheimer's therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape

Sugandhi, V. V., Gadhave, D. G., Ugale, A. R., Kulkarni, N. N., Nangare, S., Patil, H. P., Rath, S., Saxena, R., Lavate, A., Patel, A. T., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102775 · Cited by 31 · see citing works

Natural Products from Plants and Algae for Treatment of Alzheimer’s Disease: A Review

Klose, J., Griehl, C., Roßner, S., & Schilling, S. (2022) · Biomolecules · doi:10.3390/biom12050694 · Cited by 23 · see citing works

Donepezil and Embelin Loaded Nanostructured Lipid Carriers for Direct Brain Delivery as An Intervention for Alzheimer’s Disease: Formulation Design, Optimization and Evaluation

Ali, M. H., Alam, O., Ali, A., Ali, M. U., Parvez, S., Aldosari, E., Baboota, S., & Ali, J. (2023) · Journal of Cluster Science · doi:10.1007/s10876-023-02531-7 · Cited by 22 · see citing works

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

Þórðardóttir, S., Rodriguez‐Vieitez, E., Almkvist, O., Ferreira, D., Saint‐Aubert, L., Ståhlbom, A. K., Thonberg, H., Schöll, M., Westman, E., Wall, A. E., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0374-y · Cited by 21 · see citing works

Neurovascular Alterations in Alzheimer’s Disease: Transporter Expression Profiles and CNS Drug Access

McInerney, M. P., Short, J. L., & Nicolazzo, J. A. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0077-5 · Cited by 20 · see citing works

Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers

Petok, J. R., Myers, C. E., Pa, J., Hobel, Z. B., Wharton, D., Medina, L. D., Casado, M., Coppola, G., Gluck, M. A., & Ringman, J. M. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.01.022 · Cited by 21 · see citing works

Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease

Chen, C. D., Holden, T. R., Gordon, B. A., Franklin, E. E., Li, Y., Coble, D. W., Luo, H., Bateman, R. J., for the Dominantly Inherited Alzheimer Network (DIAN) and for the Dominantly Inherited Alzheimer Network Trials Unit (DIAN‐TU), Ances, B. M., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51237 · Cited by 19 · see citing works

Identification of pleiotropy at the gene level between psychiatric disorders and related traits

Polushina, T. V., Banerjee, N., Giddaluru, S., Bettella, F., Espeseth, T., Lundervold, A. J., Djurovic, S., Cichon, S., Hoffmann, P., Nöthen, M. M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01530-4 · Cited by 18 · see citing works

Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer’s Disease: A Recent Update

Pandey, M., Choudhury, H., Verma, R. K., Chawla, V., Bhattamisra, S. K., Gorain, B., Raja, M. A. G., & Amjad, M. W. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319999200819095620 · Cited by 18 · see citing works

Abnormal retinal capillary blood flow in autosomal dominant Alzheimer's disease

Singer, M., Ringman, J. M., Chu, Z., Zhou, X., Jiang, X., Shahidzadeh, A., Wang, R. K., & Kashani, A. H. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12162 · Cited by 17 · see citing works

Combination Therapy for the Treatment of Alzheimer’s Disease: Recent Progress and Future Prospects

Shirbhate, E., Patel, V. K., Tiwari, P., Kore, R., Veerasamy, R., Mishra, A., & Rajak, H. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220907114443 · Cited by 17 · see citing works

Computational Drug Repurposing for Neurodegenerative Diseases

Savva, K., Zachariou, M., Oulas, A., Minadakis, G., Sokratous, K., Dietis, N., & Spyrou, G. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00004-3 · Cited by 15 · see citing works

Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes

Almkvist, O., Rodriguez‐Vieitez, E., Þórðardóttir, S., Nordberg, A. K., Viitanen, M. H., Lannfelt, L., & Graff, C. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.06.010 · Cited by 13 · see citing works

The Clinical Spectrum of Young Onset Dementia Points to Its Stochastic Origins

Panegyres, P. K. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210309 · Cited by 12 · see citing works

The dichotomous activities of microglia: A potential driver for phenotypic heterogeneity in Alzheimer’s disease

Pumo, A., & Legeay, S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148817 · Cited by 12 · see citing works

Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease

Schultz, S. A., Shirzadi, Z., Schultz, A. P., Liu, L., Fitzpatrick, C. D., McDade, E., Barthélemy, N. R., Renton, A. E., Esposito, B. T., Joseph‐Mathurin, N., et al. (2023) · Aging Cell · doi:10.1111/acel.13871 · Cited by 11 · see citing works

Quinic acid and its derivatives protect against phytohaemagglutinin-induced Alzheimer's-like neurotoxicity in SH-SY5Y cells by down-regulating p38 MAPK signaling pathway

Rafi, K., Faizi, S., Hussain, S. S., Shamshad, S., Versiani, M. A., & Sımjee, S. U. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117539 · Cited by 10 · see citing works

Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer’s disease

Hoogmartens, J., Hens, E., Engelborghs, S., Vandenberghe, R. R., Deyn, P. P. D., Cacace, R., Broeckhoven, C. V., Cras, P. P., Goeman, J., Crols, R., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.009 · Cited by 10 · see citing works

PSEN1 c.1292C<A Variant and Early-Onset Alzheimer’s Disease: A Scoping Review

Orozco-Barajas, M., Oropeza-Ruvalcaba, Y., Canales-Aguirre, A. A., & Sánchez-González, V. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.860529 · Cited by 10 · see citing works

Haploinsufficiency and Alzheimer’s Disease: The Possible Pathogenic and Protective Genetic Factors

Bagyinszky, E., & An, S. S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211959 · Cited by 10 · see citing works

15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIAN

Daniels, A. J., McDade, E., Llibre-Guerra, J., Xiong, C.-J., Perrin, R., Ibanez, L., Supnet-Bell, C., Cruchaga, C., Goate, A., Renton, A. E., et al. (2026) · npj Dementia · doi:10.1038/s44400-025-00047-7 · Cited by 2 · see citing works

Retinotopic degeneration of the retina and optic tracts in autosomal dominant Alzheimer's disease

Adhikari, S., Qiao, Y., Singer, M., Sagare, A. P., Jiang, X., Shi, Y., Ringman, J. M., & Kashani, A. H. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13100 · Cited by 9 · see citing works

Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer’s Disease

Targum, S. D., Fosdick, L., Drake, K. E., Rosenberg, P. B., Burke, A. D., Wolk, D. A., Foote, K. D., Asaad, W. F., Sabbagh, M. N., Smith, G. S., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210530 · Cited by 8 · see citing works

Deep normative modelling reveals insights into early-stage Alzheimer's disease using multi-modal neuroimaging data

Aguila, A. L., Lorenzini, L., Janahi, M., Barkhof, F., & Altmann, A. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01753-3 · Cited by 7 · see citing works

Psychiatric Disorders in Alzheimer Disease With the Presenilin-1 L226F Mutation

Bartesaghi, F., Rosci, C. E., Rassiga, C., Barbieri, V., Gambini, O., Floro, S., D'Arrigo, A. M., Sole, A. D., Scarpini, E. A., Galimberti, D., et al. (2020) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000249 · Cited by 7 · see citing works

Τhe Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations

Kalampokini, S., Georgouli, D., Patrikiou, E., Provatas, A., Valotassiou, V. J., Georgoulias, P., Spanaki, C., Hadjigeorgiou, G. M., & Xiromerisiou, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212355 · Cited by 7 · see citing works

Developing a Gene Therapy for the Treatment of Autosomal Dominant Alzheimer's Disease

Moore, B., Sharma, A. M., Goulet, M., Suter, T. A. C. S., Pelletier, C., Hu, R., Schaeffer, E., & Kelleher, R. J. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.092 · Cited by 6 · see citing works

Proteomics as an innovative tool to investigate frontotemporal disorders

Agresta, A. M., Palma, A. D., Bardoni, A., Salvini, R., Iadarola, P., & Mauri, P. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500090 · Cited by 6 · see citing works

Inflammation—Cause or consequence of late onset Alzheimer’s disease or both? A review of the evidence

Zhao, J., Zhao, D. B., Wang, J., Luo, X., & Guo, R. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221095383 · Cited by 6 · see citing works

Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1

Tiedt, H. O., Benjamin, B., Niedeggen, M., & Lueschow, A. (2018) · Neurodegenerative Diseases · doi:10.1159/000485899 · Cited by 6 · see citing works

Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress?

Brown, R. E. (2022) · The EuroBiotech Journal · doi:10.2478/ebtj-2022-0008 · Cited by 5 · see citing works

Leveraging eQTLs to identify individual-level tissue of interest for a complex trait

Majumdar, A., Giambartolomei, C., Cai, N., Haldar, T., Schwarz, T., Gandal, M. J., Jonathan Flint, C., & Paşaniuc, B. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008915 · Cited by 5 · see citing works

A Novel Dynamic Neural Network for Heterogeneity-Aware Structural Brain Network Exploration and Alzheimer’s Disease Diagnosis

Cui, W., Leng, Y., Peng, Y., Bai, C., Li, L., Jiang, X., Yuan, G., & Zheng, J. (2025) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2025.3569650 · Cited by 4 · see citing works

Ensemblex: an accuracy-weighted ensemble genetic demultiplexing framework for population-scale scRNAseq sample pooling

Fiorini, M. R., Amiri, S., Dilliott, A. A., Ohki, C. M. Y., Smigielski, L., Walitza, S., Fon, E. A., Grünblatt, E., Thomas, R. A., & Farhan, S. M. K. (2025) · Genome biology · doi:10.1186/s13059-025-03643-1 · Cited by 4 · see citing works

Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary

Percy, M. E., & Lukiw, W. J. (2017) · International Journal of Developmental Disabilities · doi:10.1080/20473869.2017.1301023 · Cited by 4 · see citing works

Neuroprotective factors affect the progression of Alzheimer's disease

Liu, Y., & Tian, J. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.09.042 · Cited by 5 · see citing works

Revealing Individual Neuroanatomical Heterogeneity in Alzheimer’s DiseasePreprint

Verdi, S., Kia, S. M., Yong, K. X. X., Tosun, D., Schott, J. M., Marquand, A. F., Cole, J. H., & Initiative, T. A. D. N. (2022) · medRxiv · doi:10.1101/2022.06.30.22277053 · Cited by 4 · see citing works

WIMOAD: Weighted Integration of Multi-Omics Data with Meta Learning for Alzheimer’s Disease Diagnosis

Xiao, H., Wang, J., & Wan, S. (2024) · doi:10.1101/2024.09.25.614862 · Cited by 6 · see citing works

The Therapeutic Potential of Targeting the Pd-L1/Pd-1 Immune Checkpoint Pathway in Alzheimer's Disease

Mehrabadi, S. (2024) · Current Aging Science · doi:10.2174/0118746098342537241121042621 · Cited by 3 · see citing works

Integrated cellular 4D-TIMS lipidomics and transcriptomics for characterization of anti-inflammatory and anti-atherosclerotic phenotype of MyD88-KO macrophages

Calvo, C. D. B., & Bîndilă, L. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1450971 · Cited by 3 · see citing works

Improvement of cognitive performance by a nutraceutical formulation: Underlying mechanisms revealed by laboratory studies

Shea, T. B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.039 · Cited by 3 · see citing works

Síndrome de Down y enfermedad de Alzheimer: factores de riesgo, evaluación e intervención

Pérez, E. D., Gómez, L. E., & Rodríguez, M. Á. A. (2016) · Revista Española de Discapacidad · doi:10.5569/2340-5104.04.01.02 · Cited by 2 · see citing works

Association Between ABCA1 R219K Variant and Alzheimer's Disease: An Updated Meta-Analysis and Systematic Review

Zhao, J., Wang, J., Zhao, D. B., Wang, L., & Luo, X. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221114112838 · Cited by 2 · see citing works

Mental Disorders in Young Adults from Families with the Presenilin-1 Gene Mutation E280A in the Preclinical Stage of Alzheimer’s Disease

Villalba, A. C., Valencia, J. G., Ramos, C., Cuastumal, A. R., Aguillon, D. F., Aguirre–Acevedo, D. C., Madrigal, L., & Lopera, F. J. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190139 · Cited by 2 · see citing works

A Brief Review of Alzheimer’s Disease

Yavari, M. D. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.35.005747 · Cited by 2 · see citing works

Efficient algorithms for survival data with multiple outcomes using the frailty model

Huang, X., Xu, J., & Zhou, Y. (2022) · Statistical Methods in Medical Research · doi:10.1177/09622802221133554 · Cited by 2 · see citing works

Are Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease “Separate but Equal”?

Ringman, J. M. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1633 · Cited by 2 · see citing works

Computational Phenotype Discovery via Probabilistic IndependencePreprint

Lasko, T. A., & Mesa, D. A. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1907.11051 · Cited by 2 · see citing works

Magnetic resonance microscopy maps widespread effects of Alzheimer’s disease on brain structures and behavior in mice

Tian, Y., Hornburg, K., Austin, W., Cook, J. J., Qi, Y., White, L. E., Killmar, J. T., Kaczorowski, C. C., Ashbrook, D. G., Johnson, G. A., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-025-02199-4 · Cited by 1 · see citing works

Motor abilities and cognitive performance in Latinos with autosomal dominant Alzheimer's disease

Petkus, A. J., Sonti, A. N., Montoya, L., Sagare, A. P., & Ringman, J. M. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100010 · Cited by 1 · see citing works

Unsupervised discovery of clinical disease signatures using probabilistic independence

Lasko, T. A., Stead, W. W., Still, J. M., Li, T., Kammer, M. N., Mota, M. B., Strobl, E. V., Landman, B. A., & Maldonado, F. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104837 · Cited by 1 · see citing works

Toward the right treatment at the right time: Modeling the trajectory of cognitive decline to identify the earliest age of change in people with Alzheimer's disease

Baksh, R. A., Strydom, A., Carter, B., Carrière, I., & Ritchie, K. A. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12563 · Cited by 1 · see citing works

Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof‐of‐principle study and call to action

Dubbelman, M. A., Vromen, E. M., Tijms, B. M., Berkhof, J. H., Ottenhoff, L., Vijverberg, E. G. B., Prins, N. D., van der Flier, W. M., & Sikkes, S. A. M. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12485 · Cited by 1 · see citing works

Feature Selection on MRI Data for Improved Classification of Alzheimer Disease

S, S. B., & Karthikeyan, B. R. (2021) · IEEE International Conference on Electronics, Computing and Communication Technologies (CONECCT) · doi:10.1109/conecct52877.2021.9622551 · Cited by 1 · see citing works

Introductory Chapter: Beyond Risk Alleles - Invoking Cognitive Lesions in Top-Down Strategic Analysis

Larrivee, D. C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85415

Mental Disorders in Young Adults from Families with the Presenilin-1 Gene Mutation E280A in the Preclinical Stage of Alzheimer’s Disease

Villalba, A. C., Valencia, J. G., Ramos, C., Cuastumal, A. R., Aguillon, D. F., Aguirre–Acevedo, D. C., Madrigal, L., & Lopera, F. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181013

Introduction to Heterogeneity in Statistical Genetics

Gordon, D., Finch, S. J., & Kim, W. (2020) · Statistics for biology and health · doi:10.1007/978-3-030-61121-7_1

Faculty Opinions recommendation of Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.

Perani, D. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726105916.793537459

Unraveling Alzheimer's disease heterogeneity:

Vromen, E. M. (2024) · doi:10.5463/thesis.937

Global dissection of the impact of Alzheimer’s disease on brain architecture and behavior: High resolution MRH resolves robust regional effectsPreprint

Johnson, G. A., Tian, Y., Hornburg, K. J., Cook, J. J., Qi, Y. P., WHITE, L. E., KILLMAR, J. T., Kaczorowski, C. C., Ashbrook, D. G., & Williams, R. W. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.08.632011

Retinal and Optic Nerve Lesions Correspond to Amyloid in Autosomal Dominant Alzheimer’s DiseasePreprint

Kashani, A. H., Koronyo‐Hamaoui, M., Koronyo, Y., Shi, H., Alluwimi, M. S., Singer, M., Sagare, A. P., Hawes, D., Tang, A., Jiang, X., et al. (2025) · medRxiv · doi:10.1101/2025.01.21.25319904

The curious case of a heterozygous loss-of-function PSEN1 variant associated with early-onset Alzheimer’s disease

Sanjuan-Ruiz, I., Serneels, L., Craessaerts, K., Goate, A., Annaert, W. G., Chávez‐Gutiérrez, L., Shi, Y., Sheikh‐Bahaei, N., Jen, J. C., Ramos, E. M., et al. (2025) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-025-00004-x

Comparaison des effets de la viniférine et du resvératrol dans des modèles expérimentaux de la maladie d'Alzheimer

Freyssin, A. (2020) · theses.fr (ABES) · doi:10.70675/0db2e37dz547bz4731z852dz9b843c062cba

Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease

Llibre‐Guerra, J. J., Lu, R., Clarens, M. F., Liu, I., Renton, A. E., Ryan, N. S., Goate, A., Aguillón, D., Allegri, R., Benzinger, T. L. S., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214804

Redefining Polycystic Ovary Syndrome

Vafea, M. T., & Dunaif, A. E. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.08.002

WIMOAD: W eighted I ntegration of M ulti- O mics data with meta learning for A lzheimer's D isease diagnosis

Xiao, H., Wang, J., & Wan, S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261491975

Correlating familial Alzheimer’s disease gene mutations with clinical phenotype

Ryan, N. S., & Rossor, M. N. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.92 · Cited by 176 · see citing works

Functional Networks: A New Window Into Alzheimer’s Disease Subtypes

Rittman, T. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.02.002

Heterogeneity of Alzheimer’s Disease

Heyman, A. (2019) · CRC Press eBooks · doi:10.1201/9780429260353-14

Refining the understanding of typical Alzheimer disease

Jessen, F. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0259-0 · Cited by 4 · see citing works

[F4–01–04]: NEUROIMAGING AND HETEROGENEITY IN FAMILIAL ALZHEIMER'S DISEASE

Fox, N. C., Ryan, N. S., Weston, P. S. J., Chávez‐Gutiérrez, L., Marc Modat, A., Cash, D. M., Sebastien Ourselin, A., & Rossor, M. N. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.07.377